NCT01612858View on ClinicalTrials.gov

Metabolic Abnormalities in HIV-infected Persons

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
LipodystrophyHIV Infection
Interventions
DRUG

Metformin

Metformin at a dose of one 500mg tablet twice a day with meals for one week, after which the dose will increase to 500 mg three times a day with meals for the remaining 11 weeks of the study.

DRUG

Pioglitazone

Pioglitazone at a dose of one 30 mg tablet once per day for the 12 weeks of the study.

Trial Locations (1)

02111

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Tufts Medical Center

OTHER

NCT01612858 - Metabolic Abnormalities in HIV-infected Persons | Biotech Hunter | Biotech Hunter